
Cell Biology
IGF-1 LR3
Long R3 IGF-1 analog for growth-factor receptor research
IGF-1 LR3 is an 83-amino-acid synthetic analog of human insulin-like growth factor 1 containing an N-terminal extension and an Arg substitution at position 3. It is studied in IGF-1 receptor, binding-protein, and growth-factor signaling models. Offered strictly for laboratory research use only. Not for human or veterinary use.
Frequently researched together
Other laboratory research compounds available in our catalog.
Compound information
Technical specifications
What is IGF-1 LR3?
IGF-1 LR3 is a synthetic 83-residue peptide whose sequence corresponds to human insulin-like growth factor 1 with two deliberate structural changes: an extension at the amino terminus and an arginine substitution at position three. The name records both, the L for the long form created by the extension and the R3 for the arginine at the third position. Older papers spell it Long R3 IGF-I. It is supplied strictly for laboratory research use and is not for human or veterinary use.
The parent molecule is a single-chain polypeptide of the insulin superfamily, folded through internal disulfide bonds and studied largely in the context of its interactions with insulin-like growth factor binding proteins. Both modifications in this analogue sit in the amino-terminal region that the binding-protein literature treats as the principal contact surface, which is why the analogue and the native factor are so often run side by side in the same experiment.
The catalogue lists the molecular formula C400H625N111O115S9, whose nine sulphur atoms reflect the cysteine and methionine content of the chain. No CAS registry number and no molecular weight are recorded in this catalogue entry, so neither is stated here; the expected mass used for analytical comparison is calculated from the formula. The material is filed under cell-biology research materials and stocked in a 1 mg presentation.
- Molecular formula
- C400H625N111O115S9
Stability information
Recommended handling and storage conditions for retaining compound identity and integrity in the laboratory.
Store lyophilized at −20°C, protected from light. Reconstitute and refrigerate (2–8°C) for short-term research use.
Regulatory information
Development origin and regulatory status, compiled for reference.
Research compound · Not FDA-approved
Frequently asked
Questions about IGF-1 LR3
What purity is IGF-1 LR3 supplied at, and is a Certificate of Analysis available?
Yes. Each lot of IGF-1 LR3 is tested by a third-party laboratory using HPLC for purity, and the certificate of analysis for the current lot is linked on this page and in the certificate library.
How is the identity of IGF-1 LR3 verified?
Identity is confirmed by mass spectrometry against the expected molecular weight, alongside HPLC retention behaviour. Both results are recorded on the lot certificate.
How should IGF-1 LR3 be stored on receipt?
Lyophilized material is stored at -20 C protected from light. Once reconstituted it is kept at 2 to 8 C for short-term laboratory use, and repeated freeze-thaw cycles are avoided.
Where is IGF-1 LR3 shipped from?
Orders ship from the United States in discreet, tracked packaging. Shipping is available to US addresses only.
Is IGF-1 LR3 supplied for research use only?
Yes. IGF-1 LR3 is sold strictly as a laboratory research material. It is not for human or veterinary use, not for diagnostic procedures, and has not been evaluated by the U.S. Food and Drug Administration. See the research use disclaimer for the full terms.
Answers describe how this material is tested, stored and shipped. They are not guidance on any use, and this compound is not for human or veterinary use.
Sources & references
Published literature in which this compound has been the subject of laboratory or preclinical study. Listed for bibliographic reference only.
Research and educational purposes only. These references are provided for bibliographic context. They are not evidence of safety or efficacy, and nothing here is medical advice or a claim about any use in humans or animals.
Journal of cellular physiology
Effect of recombinant porcine IGFBP-3 on IGF-I and long-R3-IGF-I-stimulated proliferation and differentiation of L6 myogenic cells
The Journal of endocrinology
Production of recombinant porcine IGF-binding protein-5 and its effect on proliferation of porcine embryonic myoblast cultures in the presence and absence of IGF-I and Long-R3-IGF-I
The Journal of endocrinology
Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs
Growth factors (Chur, Switzerland)
Effects of insulin-like growth factor-I and its analogue, long-R3-IGF-I, on intestinal absorption of 3-O-methyl-D-glucose are less pronounced than gut mucosal growth responses
The Journal of endocrinology
Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig






